Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Scleroderma

Zhejiang University · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
autoimmune-diseases
scleroderma, autoimmune diseases, cd19 car t-cell therapy, bcma car t-cell therapy, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 880565
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.